MODERN VALUE INVESTING: 25 Tools to Invest With a Margin of Safety in Today's Financial Environment

by Sven Carlin

Growth and biotechnology companies often have large cash balances due to capitalization rounds which makes them seem cheap, but given their cash burn rate, they aren’t.